Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.

A relatively small telehealth company that recently went public wants to take a slice of the big pharmaceuticals companies’ hottest market. Hims & Hers Health said on Monday that it is offering weight-loss injections for as low as $199 a month, a move that capitalizes on the growing demand for such treatments. The telehealth platform started offering oral medication kits for weight loss late last year and is now expanding its roster of products as it seeks to compete with companies like Eli Lilly and Novo Nordisk.